Amanita muscaria affects the brain through two compounds that push your nervous system in opposite directions at the same time. One, muscimol, mimics your brain’s main calming chemical and suppresses neural activity. The other, ibotenic acid, overstimulates excitatory receptors and can damage neurons. The balance between these two compounds, and which one dominates, determines whether the experience is sedating, disorienting, or dangerous.
The Two Active Compounds
The red-capped mushroom contains two psychoactive molecules built around an isoxazole ring: ibotenic acid and muscimol. They’re structurally similar to two of the brain’s most important signaling chemicals, glutamate and GABA, which lets them slip past the blood-brain barrier using the brain’s own active transport system. Once inside, they bind to the same receptors those natural chemicals use, but with very different results.
A single fresh cap can contain up to 70 mg of ibotenic acid, which sits right at or above the psychoactive threshold of 30 to 60 mg. The threshold for muscimol is much lower, around 6 to 10 mg, because it’s far more potent per milligram. The ratio of these two compounds varies wildly between individual mushrooms, across regions, and depending on whether the material is fresh or dried. Drying converts some ibotenic acid into muscimol through a natural chemical process called decarboxylation, which shifts the overall effect.
How Muscimol Suppresses Brain Activity
Muscimol is the compound responsible for most of the mushroom’s psychoactive effects. It works by binding to GABA-A receptors, the same receptors targeted by alcohol, benzodiazepines, and sleep medications. GABA is the brain’s primary inhibitory signal. When it activates a receptor, it quiets the neuron, making it less likely to fire. Muscimol does the same thing, but it binds with unusual potency to a specific subset of these receptors.
Research published in the Journal of Neurochemistry found that muscimol has an exceptionally high affinity for GABA-A receptors containing a component called the delta subunit. These receptors sit outside the main communication junctions between neurons and provide a kind of background, tonic inhibition. They keep baseline brain activity in check. When muscimol locks onto these receptors, it binds at concentrations in the low nanomolar range and dissociates very slowly, meaning its inhibitory effect lingers. Mice engineered without the delta subunit showed drastically reduced sensitivity to muscimol, confirming that these specific receptors are the primary target.
This is why muscimol acts as a central nervous system depressant. It produces sedation, drowsiness, a sense of unreality, altered perception of size and distance, and in higher doses, a deep stupor. The CDC has documented cases where patients presented with central nervous system depression after consuming the mushroom.
How Ibotenic Acid Overstimulates Neurons
Ibotenic acid does the opposite. It activates NMDA receptors, one of the brain’s main excitatory receptor types normally triggered by glutamate. This pushes neurons to fire more, not less. The result can include agitation, hallucinations, muscle twitching, and in severe cases, seizures.
The more concerning property of ibotenic acid is its potential for excitotoxicity. When NMDA receptors are overstimulated, they allow excessive calcium to flood into neurons, triggering a cascade that can damage or kill the cell. Research has confirmed that ibotenic acid’s neurotoxicity operates specifically through NMDA receptor activation. The effect can be enhanced by glycine, a co-activator of NMDA receptors. In fact, neuroscientists have historically used ibotenic acid injections to create precisely targeted brain lesions in lab animals, specifically because it reliably destroys neurons through this excitotoxic mechanism.
This doesn’t mean eating a single mushroom will burn holes in your brain. The dose matters enormously. But ibotenic acid is the reason toxicologists treat Amanita muscaria as genuinely dangerous rather than simply psychoactive.
What the Experience Feels Like
Because muscimol and ibotenic acid are pulling the brain in opposite directions, the effects are unpredictable and often described as confusing rather than pleasant. A typical intoxication involves some combination of drowsiness, euphoria, visual distortions (objects appearing larger or smaller than they are), loss of coordination, agitation, and vivid dream-like states. Some people cycle between excitation and sedation.
Effects generally begin 30 to 90 minutes after ingestion and can last several hours. Unlike psilocybin mushrooms, which produce their effects by activating serotonin receptors and tend to create emotional and perceptual shifts, Amanita muscaria works on the same brain systems as alcohol and sedatives. UC San Diego researchers have described it plainly: psilocybin is an antidepressant that activates neural pathways involved in mood and optimism, while Amanita muscaria is a depressant that suppresses the central nervous system. The subjective experiences are fundamentally different, and people expecting a psilocybin-like trip are often caught off guard.
Effects on Memory and Learning
Muscimol’s action on GABA-A receptors has measurable consequences for how the brain forms and stores memories. In animal studies, muscimol induces long-term depression (LTD) in the hippocampus, the brain region most critical for forming new memories. LTD is the weakening of connections between neurons, essentially the opposite of the strengthening process (long-term potentiation) that underlies learning. Muscimol also impairs spatial memory through mechanisms that appear to operate independently of its suppression of normal synaptic strengthening.
This mirrors what’s known about benzodiazepines, which act on the same receptor family and commonly cause temporary amnesia. During intoxication, the ability to form new memories is significantly impaired. Whether repeated use causes lasting cognitive changes in humans hasn’t been formally studied, but the mechanism of action suggests that chronic, heavy use would carry real risks to memory function.
Why Dose Is So Hard to Control
One of the biggest practical dangers is the extreme variability between mushrooms. Two caps from the same patch of forest can contain very different concentrations of ibotenic acid and muscimol. Preparations also vary wildly. Analysis of homemade extracts found muscimol concentrations ranging from 0.005 to 0.07 mg/mL depending on the preparation method, a 14-fold difference. Ibotenic acid levels showed similar inconsistency, with some preparations containing barely detectable amounts and others containing meaningful doses.
Drying the mushroom converts some ibotenic acid into muscimol through heat-driven decarboxylation, which generally makes the material less neurotoxic but more sedating. More aggressive processing, such as heating to at least 175°F for an hour or more in acidic conditions (pH below 4.5), can push this conversion further. But without laboratory testing, there’s no reliable way to know how much of either compound remains in any given preparation.
Not the Same as “Magic Mushrooms”
The distinction from psilocybin mushrooms is worth emphasizing because confusion between the two drives a significant number of poisoning cases. Psilocybin binds to serotonin receptors. Muscimol binds to GABA receptors. These are entirely separate neurotransmitter systems with different roles in the brain. Serotonin receptor activation tends to increase neural connectivity and produce the “mind-expanding” effects people associate with psychedelics. GABA receptor activation does the opposite: it dampens neural activity, producing sedation and cognitive impairment.
Amanita muscaria is also legal in most jurisdictions precisely because it isn’t classified as a classic psychedelic, which has led to a growing market of unregulated products. Researchers at UC San Diego have raised concerns that these products pose genuine public health risks, particularly because consumers often assume the effects will resemble psilocybin when they’re pharmacologically closer to alcohol or sedative overdose.